益生股份(002458.SZ):7月雞苗銷售收入同比降6.79%、環比降23.21%
格隆匯8月6日丨益生股份(002458.SZ)公佈,公司2021年7月雞苗銷售數量4162.73萬只,銷售收入11528.92萬元,同比變動分別為-6.70%、-6.79%,環比變動分別為8.53%、-23.21%。
公司2021年07月種豬銷售數量28頭,銷售收入16.64萬元。同比變動分別為-20.00%、-46.11%。
原因説明如下:1、因農忙、高温等季節性因素影響,自6月下旬開始,商品代雞苗價格有所回調,自7月中旬開始,隨着季節性因素影響的消除,雞苗價格已上漲。
2、公司種豬銷售數量基數較小,客户出於生物安全考慮,通常會選擇將購買的種豬一次性集中運走,故公司月度銷售種豬數量不均衡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.